Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Diagnosis and Management of Deep Vein Thrombosis

Initial Evaluation and Testing

  • The American College of Chest Physicians recommends performing D-dimer testing, preferably highly sensitive D-dimer, to assess patients with suspected DVT, and if D-dimer is negative, DVT can be excluded, while a positive result warrants further testing with compression ultrasonography (CUS) 1
  • The initial evaluation with proximal CUS is recommended, and if negative, further testing with serial proximal CUS or sensitive D-dimer testing should be considered 1
  • The Wells score should be used for clinical probability assessment, with D-dimer testing for low-probability patients and compression ultrasound for high-probability patients, as recommended by the American College of Chest Physicians 1
  • The Wells score is calculated using the following factors:

    Factor Points
    Active cancer 1
    Paralysis, paresis, or recent immobilization 1
    Bedridden ≥3 days or major surgery within 12 weeks 1
    Localized tenderness along deep veins 1
    Entire leg swollen 1
    Calf swelling ≥3 cm larger than asymptomatic side 1
    Pitting edema confined to symptomatic leg 1
    Collateral superficial veins 1
    Previous DVT 1
    Alternative diagnosis at least as likely -2

    1, 2, 3, 4, 5

Imaging and Diagnostic Procedures

  • Compression ultrasonography (CUS) of proximal veins is recommended, and if CUS is positive, DVT can be confirmed, while a negative result may require additional testing based on clinical suspicion 1
  • Ultrasound is the initial imaging modality of choice for suspected DVT, but has lower sensitivity for distal DVT (63.5% for below-knee DVT) and anatomical limitations, with less consistent diagnostic performance above the inguinal canal and below the knee 5
  • For suspected isolated iliac vein thrombosis, dedicated iliac vein imaging, such as Doppler US, MRI direct thrombus imaging, or venography, should be considered, especially in patients with entire leg swelling or buttock/back pain 1
  • CT venography or MR venography can be used to evaluate suspected iliac vein thrombosis, as recommended by the American College of Radiology 5
  • Cancer patients have a higher risk of DVT, particularly with certain types of cancer, and early use of CT venography (CTV) or MR venography (MRV) should be considered if initial ultrasound is negative but clinical suspicion remains high, as advised by the National Comprehensive Cancer Network 6, 7, 8
  • Pregnant patients with suspected DVT should undergo compression ultrasound and serial ultrasound evaluations (days 0, 3, and 7) if initial test is negative, and MR venography should be considered for suspected isolated pelvic DVT 2

Clinical Follow-up and Management

  • Clinical follow-up is essential, even when testing rules out DVT, and patients should be instructed to return if symptoms worsen or fail to resolve, as recommended by the American College of Chest Physicians 1
  • The American College of Chest Physicians recommends initiating anticoagulation therapy immediately when DVT is confirmed, with direct oral anticoagulants (DOACs) preferred over vitamin K antagonists due to equal effectiveness, improved safety profile, and greater convenience 1
  • Treatment options include DOACs without initial parenteral therapy (apixaban or rivaroxaban), parenteral anticoagulant (LMWH) followed by dabigatran or edoxaban, or LMWH overlapped with warfarin 1
  • For DVT associated with transient risk factors, short-term therapy (3 months) is recommended, while unprovoked DVT or persistent risk factors (e.g., cancer) may require long-term anticoagulation 1
  • Prophylactic anticoagulation should be considered in high-risk patients while awaiting definitive diagnosis, to prevent delays in anticoagulation, with a standard prophylactic dose of enoxaparin of 40 mg subcutaneously once daily, as recommended by the American College of Chest Physicians 1
  • The American College of Cardiology recommends starting with ankle-brachial index (ABI) measurement with pulse volume recordings (PVR) and/or Doppler waveforms for suspected peripheral arterial disease (PAD), deep vein thrombosis (DVT), and statin-induced myopathy 9
  • An abnormal ABI is defined as ≤0.90, borderline as 0.91-0.99, normal as 1.00-1.40, and noncompressible as >1.40, according to the American College of Cardiology 9
  • If ABI >1.40 (noncompressible vessels), the European Heart Journal recommends performing toe pressure/toe-brachial index (TBI) with waveforms, with a normal TBI defined as >0.70 and abnormal as ≤0.70 10
  • The European Heart Journal recommends assessing lipid profile, including total cholesterol, LDL-C, HDL-C, triglycerides, and lipoprotein(a), as well as evaluating glucose metabolism with fasting glucose and HbA1c, renal function with creatinine and estimated GFR, and complete blood count 10
  • Coagulation studies, including D-dimer, and inflammatory markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), are also recommended by the European Heart Journal 10
  • Electrolyte assessment is also recommended by the European Heart Journal 10

REFERENCES

3

prostate cancer, version 1.2014. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

8

venous thromboembolic disease. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2011